瑞銀:雅生活服務(3319.HK)股東減持不影響基本面 評級維持“買入”
雅生活(03319.HK)主要股東綠地金融出售5,000萬股公司H股,每股平均作價21.18元,涉資約10.59億元。完成後,綠地金融共計持有公司5,000萬股H股及1億股非上市股份,持股降至11.25%,仍是第二大股東。
瑞銀髮表報告指,相信投資者關注綠地金融何時會出售其持有之餘下5,000萬股,惟認為是次出售不影響雅生活之基本因素,加上雅生活很大機會納入港股通,業務亦擴屋至公營地產管理項目,仍為該行首選,評級“買入”,目標價26.9港元。現價相當於2020年預測市盈率15.6倍,預測2019至2021年每股盈利複合增長率35%,相比之下,行業平均為22倍及29%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.